Clinical Trial Update: Study of NAC of GA Therapy for Patients With BRPC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NAC of GA therapy in pancreatic ductal adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• NAC of GA therapy

Snippet

Sponsor: Wakayama Medical University | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: UNKNOWN